Book Contribution | published - printed | peer reviewed
Assessing Individualized Medicine — The example of immunoadsorption
http://www.springer.com/biomed/book/978-3-319-11718-8
Bibliographic information
ISBN: 978-3-319-11719-5
Authors
Published in
Fischer T (ed.), Langanke M (ed.), Marschall P (ed.), Michl S (ed.)
Springer-Verlag
Cham Heidelberg New York Dordrecht London 2015 | Series Advances in Predictive, Preventive and Personalised Medicine
323 pages
Individualized medicine, ethical, economical and historical perspectives
Springer-Verlag
Cham Heidelberg New York Dordrecht London 2015 | Series Advances in Predictive, Preventive and Personalised Medicine
323 pages
Further Chapters
Bahls T, Liedtke W, Geidel L, Langanke M
Ethics Meets IT: Aspects and elements of Computer-based informed consent processing
Ott K, Fischer T
On a Philosophy of Individualized Medicine: Conceptual and Ethical Questions
Langanke M, Lieb W, Erdmann P, Dörr M, Fischer T, Kroemer H, Fleßa S, Assel H
The Meaning of “Individualized Medicine”: A Terminological Adjustment of a Perplexing Term
Grabe H, Wallaschofski H
Individualized Medicine within the GANI_MED Project
Michl S
Inventing Traditions, Raising Expectations. Recent Debates on “Personalized Medicine”
Michl S
The “Epistemics” of “Personalized Medicine”. Rebranding Pharmacogenetics
Dörr M, Völker U, Felix S
Use of Biomarkers for the Prediction of Treatment Response: Immunoadsorption in Dilated Cardiomyopathy as a Clinical Example
Meyer Zu Schwabedissen H
The Role of Pharmacogenomics in Individualized Medicine
Pöder J, Assel H
The Concept of Disease in the Era of Prediction
Langanke M, Fasold J, Erdmann P, Lorbeer R, Liedtke W
Informed Consent in GANI_MED — A sectional design for clinical epidemiological studies within Individualized Medicine
Erdmann P
Handling incidental findings from imaging within IM related research—Results from an empirical-ethical Study
Fleßa S, Marschall P
Individualized Medicine: From potential to macro innovation
Laslo T, Marschall P, Fleßa S
How Individualized is Medicine Today? The case of heart failure in the G-DRG system
Ethics Meets IT: Aspects and elements of Computer-based informed consent processing
Ott K, Fischer T
On a Philosophy of Individualized Medicine: Conceptual and Ethical Questions
Langanke M, Lieb W, Erdmann P, Dörr M, Fischer T, Kroemer H, Fleßa S, Assel H
The Meaning of “Individualized Medicine”: A Terminological Adjustment of a Perplexing Term
Grabe H, Wallaschofski H
Individualized Medicine within the GANI_MED Project
Michl S
Inventing Traditions, Raising Expectations. Recent Debates on “Personalized Medicine”
Michl S
The “Epistemics” of “Personalized Medicine”. Rebranding Pharmacogenetics
Dörr M, Völker U, Felix S
Use of Biomarkers for the Prediction of Treatment Response: Immunoadsorption in Dilated Cardiomyopathy as a Clinical Example
Meyer Zu Schwabedissen H
The Role of Pharmacogenomics in Individualized Medicine
Pöder J, Assel H
The Concept of Disease in the Era of Prediction
Langanke M, Fasold J, Erdmann P, Lorbeer R, Liedtke W
Informed Consent in GANI_MED — A sectional design for clinical epidemiological studies within Individualized Medicine
Erdmann P
Handling incidental findings from imaging within IM related research—Results from an empirical-ethical Study
Fleßa S, Marschall P
Individualized Medicine: From potential to macro innovation
Laslo T, Marschall P, Fleßa S
How Individualized is Medicine Today? The case of heart failure in the G-DRG system
Projects
GANI_MED Greifswald Approach to Individualized Medicine (Projektverbund)
GANI_MED Teilprojekt PB3 1: Ökonomische Bewertung der Individualisierten Medizin
GANI_MED Teilprojekt PB3 1: Ökonomische Bewertung der Individualisierten Medizin